A mouse mammary tumor virus env-like exogenous sequence is strictly related to progression of human sporadic breast carcinoma by Mazzanti, Cm et al.
ASIP
2011 AJP
CME ProgramSee related Commentary on page 1588
The American Journal of Pathology, Vol. 179, No. 4, October 2011
Copyright © 2011 American Society for Investigative Pathology.
Published by Elsevier Inc. All rights reserved.
DOI: 10.1016/j.ajpath.2011.06.046Tumorigenesis and Neoplastic Progression
A Mouse Mammary Tumor Virus env-Like Exogenous
Sequence Is Strictly Related to Progression of
Human Sporadic Breast CarcinomaChiara Maria Mazzanti,* Mohammad Al Hamad,*
Giovanni Fanelli,* Cristian Scatena,*
Francesca Zammarchi,* Katia Zavaglia,*
Francesca Lessi,* Mauro Pistello,†
Antonio Giuseppe Naccarato,* and
Generoso Bevilacqua*
From the Division of Surgical, Molecular, and Ultrastructural
Pathology * and the Department of Experimental Pathology,†
University of Pisa and Pisa University Hospital, Pisa, Italy
A viral etiology of human breast cancer (HBC) has
been postulated for decades since the identification of
mouse mammary tumor virus (MMTV). The detection
of MMTV env-like exogenous sequences (MMTVels) in
30% to 40% of invasive HBCs increased attention to
this hypothesis. Looking for MMTVels during cancer
progression may contribute to a better understanding
of their role in HBC. Herein, we analyzed HBC prein-
vasive lesions for the presence of MMTVels. Samples
were obtained by laser microdissection of FFPE tis-
sues: 20 usual-type ductal hyperplasias, 22 atypical
ductal hyperplasias (ADHs), 49 ductal carcinomas
in situ (DCISs), 20 infiltrating ductal carcinomas
(IDCs), and 26 normal epithelial cells collateral to a
DCIS or an IDC. Controls included reductive mam-
moplastic tissue, thyroid and colon carcinoma, and
blood samples from healthy donors. MMTVels were
detected by fluorescence-nested PCR. DNA samples
from the tissues of nine patients were analyzed by
real-time quantitative PCR, revealing a different vi-
ral load correlated with stage of progression. Fur-
thermore, as never previously described, the pres-
ence of MMTVels was investigated by chromogenic
in situ hybridization. MMTVels were found in 19%
of normal epithelial cells collateral to a DCIS or an
IDC, 27% of ADHs, 82% of DCISs, and 35% of IDCs.
No MMTVels were found in the control samples.
Quantitative PCR and chromogenic in situ hybrid-
ization confirmed these results. These data could
contribute to our understanding of the role ofMMTVels in HBC. (Am J Pathol 2011, 179:2083–2090; DOI:
10.1016/j.ajpath.2011.06.046)
Despite the fact that breast carcinoma represents the
most frequent cancer in women and that it has been
largely studied worldwide for many decades, its etiology
is largely unknown. The hereditary transmission of patho-
genetic mutations of some predisposing genes, such as
BRCA1 and BRCA2, is the only factor recognized as
causative in this disease.1 Although the pathogenetic role
of estrogens is well demonstrated, sound evidence of
their etiological effect is still lacking.2 A minimal percent-
age of cases are caused by radiation.3
On the other hand, in mice, the etiological role of
mouse mammary tumor virus (MMTV) in the development
of tumors of the mammary gland has been demonstrated
for a long time.4 Notably, much of what is known about
the pathogenesis of human breast carcinoma (HBC) was
learned by the experimental model of the MMTV-induced
mouse mammary tumors.5,6 In particular, the concept of
cancer progression and the recognition of the so-called
preinvasive lesions as morphological steps of its devel-
opment are based on the MMTV model.7 Moreover, the
promotional role of estrogens was built on the observa-
tions conducted in mice.8,9 The strong similarities be-
tween the human and the murine disease led to a half-
century quest for a possible viral etiology of breast
carcinoma in women. MMTV viral antigens were found in
human breast tumors,10 MMTV particles were described
in human cells and milk,11,12 and MMTV sequences were
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considered conclusive mainly because of their scarce
reproducibility. Moreover, until a few years ago, the in-
volvement of viruses in the etiology of human solid tumors
did not receive much attention and the researchers were
not stimulated in this direction. Finally, the identification of
endogenous MMTV sequences in humans was a discour-
aging element.
In 1995, Wang et al14 selected a 660-bp region of
MMTV with a nucleotide sequence identity of only 16%
to human endogenous retroviral element K10, which is
highly similar to MMTV, and 90% to 98% identical to the
MMTV envelope (env) gene. By using MMTV-specific
primers located in the 660-bp region, Wang et al14
identified an MMTV env gene–like exogenous se-
quence (MMTVels) in 38% of a series of human infil-
trating breast carcinomas. On the other hand, MMTV-
els was found in only 2% of normal human breast
samples. Several other groups15–17 were able to con-
firm these data; however, negative results were also
published.18,19 These discrepant findings could be the
consequence of differences in technical procedures,
tissue heterogeneity, and the facts that there are only a
few copies of env sequences present and earlier tech-
niques were not highly sensitive. In 2006, Zammarchi et al,20
from this laboratory, designed a rigorous methodological
approach able to overcome these difficulties, based on the
application of a laser microdissection procedure and a
highly sensitive fluorescence-nested PCR. The MMTVels
was detected in 33% of a series of HBCs, whereas normal
breast tissues and other types of human tumors were neg-
ative for it.
Today, the idea that a virus could be involved in the
etiology of HBC is receiving much more attention that in
the past. In general, most research21,22 has been re-
stricted to the demonstration of viral particle proteins in
tumor cells. However, the ability of MMTV to infect human
cells was demonstrated.23
MMTV, if really involved in breast human carcino-
genesis, could act as a promoting agent or as an
etiological/pathogenic cofactor linked to some steps of
cancer progression, such as infiltration or metastasis.
The determination of where MMTV exogenous se-
quences appear during cancer progression could help
unveil their role in HBC. This study analyzes the pres-
ence of MMTVels in a series of preinvasive breast
lesions [ie, usual ductal epithelial hyperplasia (UDH),
atypical ductal epithelial hyperplasia (ADH), ductal
carcinoma in situ (DCIS), and infiltrating ductal carci-
noma (IDC)]. Moreover, the contemporary presence of
the exogenous viral sequence in normal epithelium,
preinvasive lesions, and infiltrating cancer, all from the
same patient, was also investigated. Results demon-
strate an early appearance of MMTV env-like se-
quences in HBC progression. Real-time quantitative
PCR (qPCR) fully confirms the PCR data. For the first
time, to our knowledge, we report the presence of the
MMTV env-like viral sequence by chromogenic in situ
hybridization (CISH) experiments, which detected viral
sequence hybridization signals in the nuclei of DCIS
and IDC cells.Materials and Methods
All tissues, formalin fixed and paraffin embedded, were
collected and archived (from January 1, 2005 to Decem-
ber 31, 2009) at the Division of Surgical, Molecular, and
Ultrastructural Pathology, University of Pisa, Pisa, Italy.
Epithelial cells (normal, hyperplastic, dysplastic, and
neoplastic) were obtained by laser microdissection. DNA
was extracted from microdissected tissues, and MMTV
env-like sequences were detected by fluorescence-
nested PCR and sequenced.20 In nine cases, real-time
qPCR was performed.
Histological Criteria
The adjective collateral is used to indicate normal epithe-
lial cells (NECs) present in the same histological section,
hosting a preinvasive lesion or an infiltrating carcinoma,
and preinvasive lesions present in the same histological
section, hosting an infiltrating carcinoma. UDH indicates
a benign ductal epithelial proliferative lesion character-
ized by secondary lumens and streaming of the central
proliferative cells. ADH has cytological and architectural
features of low-grade DCIS present in one or more ducts
or in an aggregate not exceeding 0.2 cm. DCIS can be of
high, intermediate, or low grade: i) pleomorphic large
cells with abundant mitoses and with variable architec-
ture, often solid and with central necrotic debris; ii) uni-
form cells with small nuclei and frequently with a cribri-
form or micropapillary configuration; and iii) neoplastic
nuclei, showing pleomorphism of a degree between high-
and low-grade DCIS.24–26
Specimens
The specimens included 26 NECs collateral to DCIS or
IDC; 20 UDHs noncollateral to DCIS or IDC; 22 ADHs
noncollateral to DCIS or IDC; 49 DCISs, 20 of which were
collateral to IDC; and 20 IDCs. Of the DCISs, 15 were
poorly differentiated, 33 were moderately differentiated,
and one was well differentiated. The negative control
included 20 NECs from reductive mammoplastic tissues,
six papillary thyroid carcinomas, six colon adenocarcino-
mas, and DNA extracted from blood samples from six
healthy blood donors. The DNA of a mouse infected by
MMTV was the positive control.
Laser Microdissection
A Leica ASLMD automatic laser microdissector (Leica
Microsystems, Wetzlar, Germany) was used to select the
epithelial cell population to be studied. Sections (6-m
thick) were cut from each case using a new microtome
blade for each slide, obtaining a total of 10,000 to 15,000
cells. Stromal and inflammatory cells were carefully ex-
cluded. Because of the long experience of the laboratory
with this method, there was no difficulty in selecting areas
of interest.20
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Microdissected samples were kept overnight in lysis buf-
fer containing proteinase K. Samples were processed for
specific PCR amplification the next day. To avoid cross
contamination, blank DNA samples (water) were pro-
cessed in parallel with the tissue samples. The quality
and amount of extracted DNA were evaluated by aga-
rose gel electrophoresis and UV spectrophotometry
(NanoDrop 2000, Thermoscientific, Wilmington, DE).
DNA Amplification Suitability
DNA was checked for the absence of PCR inhibitors by
amplifying HERV-K10 provirus target templates as posi-
tive controls. The cycle conditions were as follows: one
cycle at 94°C for 10 minutes; 30 cycles at 94°C for 30
seconds, 50°C for 30 seconds, and 72°C for 45 seconds;
and a final extension at 72°C for 7 minutes in 30-L reaction
mixture containing 1 PCR Buffer [500 mmol/L KCl, 150
mmol/L Tris-HCl (pH 8.0), 1.5 mmol/L MgCl2, 200 mol/L
each 2=-deoxyribonucleoside 5=-triphosphate, 0.5 mol/L of
forward and reverse primer, and 2.5 U AmpliTaq Gold;
Applied Biosystems]. DNA samples were considered free
of PCR inhibitors ifHERV-K10 amplicons were clearly visible
on a 1.8% agarose gel.
MMTV Sequence Detection
Fluorescence-nested PCR was used to detect the pres-
ence of the MMTV env-like sequence. Generated fluores-
cent amplicons were sized on an automatic DNA se-
quencer. The pairs of primer were designed on the basis
of the sequence available in GenBank (accession no.
AF243039). Slight changes were introduced to our pre-
vious procedure20 to adapt it to paraffin-embedded tis-
sues. They mainly consisted of decreasing the length of
the amplicons to a maximum of 250 bp. The outer primers
yield a 248-bp fragment from nucleotide positions 231 to
480 of MMTV-like env, and the inner primers yield a
202-bp fragment (nucleotide positions 231 and 431). Se-
quences of the outer primers for the first PCR were as
follows: forward, 5=-GATGGTATGAAGCAGGATGG-3=;
and reverse, 5=-CCTCTTTTCTCTATATCTATTAGCTGAG-
GTAATC-3=. For the nested PCR, the forward primer se-
quence was the same as the one previously listed,
whereas the reverse sequence was reverse nested (5=-
AAGGGTAAGTAACACAGGCAGATGTA-3=). Both PCRs
were performed in 50 L containing 1 standard PCR
buffer [1.5 mm MgCl2, 200 m each 2=-deoxyribonucleo-
side 5=-triphosphate, 0.5 mol/L unlabeled reverse
primer (MWG Biotech, Ebersberg, Germany), 0.5 mol/L
6-FAM–labeled forward primer (Applied Biosystems, Mi-
lan, Italy), and 2.5 U AmpliTaq Gold]. Input target tem-
plate was 500-ng genomic DNA in the first-round PCR
and 2 L of first-round PCR product in the second round.
The amplification profile was as follows: one cycle at 94°C
for 10 minutes; 40 (first-round) and 30 (second-round) cy-
cles at 94°C for 45 seconds, 58°C for 45 seconds, and 72°C
for 60 seconds; and a final extension at 72°C for 7 minutes.
To exclude PCR contamination, water controls and neg-ative DNA samples were included every five samples in
each run. Fluorescent amplicons were analyzed by cap-
illary electrophoresis and appeared as peaks in an elec-
tropherogram. The amplicon size was extrapolated from
a molecular size ladder resuspended in PCR buffer and
run in parallel. Briefly, 3 L of PCR products from both
amplification rounds were mixed with 0.5 L of ROX-
labeled size standard (Gene Scan 400 HD ROX; Applied
Biosystems) and 11.5 L of formamide (Hi-Di Formam-
ide; Applied Biosystems). After denaturation at 95°C for 3
minutes, samples were loaded onto an ABI PRISM 3100
automatic genetic analyzer and analyzed using
GENESCAN software, version 3.1 (Applied Biosystems,
Foster City, CA).
Sequencing of MMTV env-Like PCR Fragments
and CISH Probe
MMTVels PCR fragments and MMTV CISH probe were
purified on agarose gels using the QIAquick Gel Extrac-
tion kit (Qiagen, Valencia, CA) and sequenced on an ABI
PRISM 3130XL instrument (Applied Biosystems). Each
sequence was aligned by using the BLAST search func-
tion (Basic Local Alignment Search Tool, http://blast.
ncbi.nlm.nih.gov, last accessed March 8, 2010) to MMTV
sequences deposited in GenBank.
MMTV Real-Time PCR Assay
Extracted DNA from nine patients was analyzed by
qPCR. In two patients, NEC, DCIS, and IDC were avail-
able, whereas in the other seven patients, only DCIS and
IDC were available. Briefly, a 25-L PCR mixture was
prepared using 2 Master Mix (MesaGreeen qPCR; Eu-
rogentec, San Diego, CA) and 0.5 L of MMTV primer
(0.3 mol/L) for the env region (nested PCR, 202 bp). The
viral load was determined as the mean of triplicate sam-
ple values. The amplification of DNA from glyceraldehyde-
3-phosphate dehydrogenase (GAPDH), which is a single-
copy gene, was used as an internal reference control. Four
10-fold dilutions (1 101 to 1 104 copies/mL) of genomic
human DNA (GAPDH) and of MMTV env amplicon were
included as standard curves on each plate. MMTV env-like
and corresponding GAPDH PCR measurements were per-
formed in the same plate to minimize experimental errors.
An MMTV-positive control DNA extracted from a mouse
known to be infected with the virus and a template-negative
control (PCR mix only) were also included in each PCR run.
The PCRs were performed on the Rotor-Gene Q (Qiagen).
The standard curves were plotted by the Rotor-Gene soft-
ware detector system printing the CT values against each
known concentration of standards (MMTV or GAPDH se-
quence), and MMTV copy number per DNA sample was
calculated by the detector.
CISH Analyses
The MMTV CISH probe was prepared in-house by ampli-
fication of a 2.7-kb PCR product using primers previously
described.27 The PCR was conducted in a 50-L volume
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kara Bio Inc., Shiga, Japan), 5 L of 10 PCR buffer, 2
L of 50 mmol/L MgCl2, 8 L of 2.5 mmol/L 2=-deoxyri-
bonucleoside 5=-triphosphate, 0.2 L of each primer (5L
and LTR3),27 and 1 g of mouse genomic DNA positive
for the MMTV virus. The PCR conditions were as follows:
94°C for 2 minutes, followed by 40 cycles of 94°C for 5
seconds and 68°C for 5 minutes. The amplified probe
was labeled using the DIG-NICK translation mix kit
(Roche, Basel, Switzerland). The CISH experiments were
performed as follows: paraffin-embedded sections were
cut (4-m thick), mounted onto positively charged micro-
scope slides, and left to dry overnight at 37°C. Sections
were then deparaffinized and rehydrated. Antigen re-
trieval was achieved by heat retrieval using a water bath
(Dako, Glostrup, Denmark). The slides were placed in
Coplin jars (Sigma-Aldrich, St. Louis, MO) containing
enough 0.01 mol/L sodium citrate solution (pH 6.0) to
cover the sections, then incubated in a water bath at
80°C for 30 minutes. To expose the nuclear components,
proteinase K was applied on the sections for 10 minutes
at 37°C. The denaturation and hybridization procedures
were achieved by applying 500 ng of MMTV CISH probe
on the sections for 5 minutes at 80°C and for 16 hours at
37°C, respectively, using a ThermoBrite hybridizer
(ABBOTT, Abbott Park, IL). Finally, the results were de-
tected by applying anti-digoxigenin-AP conjugate for 30
minutes at 37°C, which produced a characteristic nuclear
black stain using NBT-BCIP substrate.
For each run of staining, positive and negative control
slides were also prepared. The positive control slides
were prepared from a case known to be positive for
MMTVels in the PCR study. The negative control slides
were prepared from the same tissue block but incubated
with hybridization buffer instead of the MMTV CISH
probe, from breast tissue negative for the presence of
viral sequences, and from colon cancer tissue.
Statistical Analyses
A one-way analysis of variance test was used to statisti-
cally evaluate the differences in viral copy numbers be-
tween the early and later stages of tumor progression in
the same patient.
Results
Our use of laser microdissection shows that only neoplastic
cells were selected for molecular studies, when comparing
Figure 1. Accuracy of laser microdissection. The comparison between the
two pictures demonstrates that only neoplastic cells were selected for mo-
lecular studies. DCIS before (A) and after (B) laser microdissection.representative DCIS before laser microdissection (Figure
1A) with DCIS after laser microdissection (Figure 1B).
Presence and Frequency of MMTV env-Like
Sequences
The presence and the frequency of MMTVels in normal
breast and in all phases of breast cancer progression are
described later and reported in Table 1 and in Figure 2.
For NECs, exogenous MMTVels were found in 19% (5 of
Table 1. Presence and Frequency of MMTVels in 49 DCISs and
in Concomitant c-NECs and IDCs
Sample
no. c-NECs DCISs IDCs
Sample
no. c-NECs DCISs IDCs
1    26 NA  
2    27 NA  
3    28 NA  NA
4    29 NA  NA
5   NA 30 NA  NA
6    31 NA  NA
7    32 NA  NA
8    33 NA  NA
9    34 NA  NA
10 NA   35 NA  NA
11 NA   36 NA  NA
12    37 NA  NA
13    38 NA  NA
14    39 NA  NA
15 NA   40 NA  NA
16 NA   41   
17    42   NA
18   NA 43   NA
19   NA 44   NA
20   NA 45   NA
21   NA 46 NA  
22   NA 47 NA  NA
23   NA 48 NA  NA
24   NA 49 NA  NA
25   NA
Positive results were as follows: c-NECs, 5 (19.0%) of 26; DCISs, 40
(82.0%) of 49; IDCs, 7 (35.0%) of 20; DCISs  IDCs, 7 (35.0%) of 20;
DCISs  IDCs  c-NECs, 1 (8.0%) of 13; and c-NECs  DCISs, 5 (24%) of
21.
NA, not assessed.
Figure 2. Percentage of MMTVels-positive cases in different histological
stages of breast cancer progression and in control tissues. CC, colon carci-
noma; c-NEC, NECs collateral to DCIS or IDC; NB, normal blood samples;
nc-NEC, NECs noncollateral to DCIS or IDC (reductive mammoplasty); TC,
thyroid carcinoma.
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normal breast samples obtained by reductive mammo-
plasty were all negative. For ductal epithelial hyperplasia,
the 20 cases of UDH were all negative for MMTVels, but
exogenous MMTV env-like sequences were found in 27%
(6 of 22) samples of ADH. For breast carcinoma, MMTV-
els were found in 82% (40 of 49) of DCIS samples; 35%
(7 of 20) of IDC samples were positive. As for controls,
the six cases of infiltrating papillary thyroid carcinoma,
the six cases of colon adenocarcinoma, and the six DNA
samples of healthy donors were negative. Regarding dif-
ferent histological structures obtained from the same pa-
tient, normal breast and IDC were also available from 13
patients with DCIS positive for MMTVels. In one case
(case 1), all three samples were positive; in four cases
(cases 6 to 9), both DCIS and IDC were positive, whereas
the normal structures were negative; in three cases
(cases 2 to 4), normal structures and DCIS were positive
and IDC was negative; and in six cases (cases 12 to 17),
only DCISs were positive. In the six patients (cases 41 to
46) with DCISs negative for MMTVels, in whom normal
structures and/or IDC were available, the normal struc-
tures and IDCs were negative. Of four cases of positive
DCISs in which IDCs were available, the latter was pos-
itive in two cases and negative in two cases (cases 10 to
11 and 26 to 27, respectively). In nine cases of positive
DCISs in which only normal gland structures were also
available, eight (cases 18 to 25) of the latter were nega-
tive and one (case 5) was positive. In the 16 cases with
only DCISs available, 13 (cases 28 to 40) were positive
and three (cases 47 to 49) were negative.
Sequence Detection
To determine whether the amplified fragments were homol-
ogous to MMTV, the 248-bp amplicons were sequenced
and aligned to the corresponding region of the prototype
MMTV sequence and MMTV (GenBank accession no.
Figure 3. MMTVels qPCR conducted on seven samples for which both DCIS
and IDC were available. The viral load was determined as the mean of
triplicate sample values represented by the virus/GAPDH copy number gene
ratio. A statistical difference was found in MMTV copy number between the
two stages, showing a dramatic decrease moving from DCIS to IDC (P 
0.01). In two patients, NECs collateral to DCIS or IDC, DCIS, and IDC were
available (insets: A and B). In each of them, there is an increase in MMTV
DNA copy number moving from normal epithelium to DCIS, whereas there
is a complete loss of the virus in IDC. ANOVA, analysis of variance.AY152 721 and no. AF243039, respectively). Multiple nu-cleotide alignment showed 97% homology to both MMTV
and human mammary tumor virus env sequences. Finally,
no significant hits were foundwhen the two sequences were
compared with the human genome sequences available in
GenBank, indicating that these amplicons were not of hu-
man genomic or endogenous retrovirus origin.
MMTV Viral Load with qPCR
qPCR was conducted on DNA extracted from DCIS and
IDC from seven different patients. GAPDH was used as
the internal gene reference control; therefore, each bar
represents the MMTV/GAPDH DNA copy number ratio
(Figure 3). The average of the MMTV/GAPDH DNA copy
number ratio (Figure 3A) for DCIS and IDC of seven sam-
ples is also shown. There was a statistically significant dra-
matic decrease in MMTV copy number between the two
stages (P  0.01). qPCR was also conducted on DNA
extracted from NEC, DCIS, and IDC from two different pa-
tients (Figure 3). In each patient, the PCR result was positive
in NECs and DCISs but negative in IDCs. In both patients,
there was an increase in MMTV DNA copy number after the
progression from normal epithelium to DCIS but a complete
loss of the virus in the invasive stage.
MMTV CISH Detection
As shown in Figure 4, MMTV-like sequences were suc-
cessfully detected by CISH in DCIS samples. None of the
negative cases revealed any CISH signal. The CISH sig-
nals were present inside the nuclei (Figure 4B), whereas
Figure 4A shows the complete absence of nuclear signal.
The multiple number of signals coming from each nu-
cleus varies among cells, with an average of 3.5; in ad-
dition, there are much fewer cells with hybridization sig-
nals in the IDC than in the DCIS cases (data not shown).
Discussion
The etiology of the sporadic breast carcinoma is un-
known, with the exception of rare radiation-induced neo-
plasms.3 The promoting role of estrogens has been well
established for many years, but sound evidence of their
possible causative action is still lacking.2
The molecular approach to breast cancer pathogene-
sis clearly demonstrates that the classic distinction be-
tween ductal and lobular carcinoma is giving place to a
Figure 4. CISH on DCIS using a 2.7-kb MMTV probe. Negative (A) and
positive (B) cases, in which numerous hybridization signals are evident in the
nuclei of cancer cells. Insets are a magnification of the area in the small
square.
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tics.28–30 The provisory molecular classification in use is
clarifying that the group of ductal carcinoma, accounting
for approximately 80% of all types of breast carcinoma,
contains an unpredictable number of different molecular
subtypes. This molecular heterogeneity could be the con-
sequence of different causative agents or of different
transforming pathways caused by the same agent. In
summary, no etiological factor has been identified for
sporadic breast cancer; it is possible that different factors
exist; and it is also possible that one or a few factors can
give origin to the many molecular pathways of breast
carcinoma by using different transforming mechanisms.
A possible viral etiology is receiving a certain consid-
eration, mainly because the demonstration of the caus-
ative role of human papilloma virus for carcinoma of the
cervix31 has opened this new frontier. In addition, several
articles20–22 have demonstrated the presence of exoge-
nous MMTV sequences in infiltrating human tumors. The
amount of information about the possible existence of a
human MTV that has accumulated during the past sev-
eral decades is considerable: i) viral particles in milk and
tumor tissues,11,12,21,32 ii) reverse transcriptase in milk,33
iii) MMTV antigens in serum and tumors,34 iv) the epide-
miological observation that HBC incidence is higher in
geographic areas where Mus domesticus is the most
prevalent mouse species,35 v) the association between
breast cancer and lymphoma,36 vi) the occurrence of
breast cancer in husbands and wives,37,38 and finally, vii)
the presence of exogenous MMTV sequences in 30% to
40% of HBCs.14,20 Interestingly, a recent article39 shows
a higher expression of Wnt1 protein in human DCISs and
IDCs positive for MMTVels. Moreover, another recent ar-
ticle40 describes the presence of MMTV-like sequences
in milk from healthy lactating women. Unfortunately, none
of these data, alone or combined, is sufficient to demon-
strate that the most common cancer in women is caused
by MMTV. On the other hand, there is no element clearly
against this hypothesis, whereas the quantity and quality
of data justify continuing to explore this possibility.
Concerning the MMTV env-like sequence, it seems
possible that some negative results were the conse-
quence of the low quantity of env sequences and/or tech-
nical and methodological problems. A recent article20
from this laboratory demonstrates that a correct ap-
proach can avoid these limitations (in particular, a laser
microdissection procedure to obtain a pure and enriched
population of tumor cells and a highly sensitive fluores-
cence-nested PCR for DNA analysis). On the basis of all
of the data in the literature, it is reasonable to conclude
that the presence of exogenous sequences of MMTV in
infiltrating HBC is real and that the percentage of positive
cases is between 30% and 40%. A recent article41 on
human RNA rumor viruses acknowledges that our previ-
ous PCR/laser microdissection approach,20 together with
in situ PCR studies,42 supports the specific association of
MMTV-like DNA and RNA with tumor cells and strength-
ens the argument that MMTV-like sequences are present
in some HBCs.
If MMTVels is involved in human breast carcinogene-
sis, it could play an early, intermediate, or late role. Inother words, it could behave as a transforming agent, an
etiological cofactor, and/or a pathogenetic agent. The
establishment of when exogenous viral sequences ap-
pear during the natural history of the disease would rep-
resent an interesting contribution to answer the previous
question. This article investigates, for the first time to our
knowledge, the presence of MMTVels in preinvasive le-
sions, infiltrating carcinomas, and normal tissues. MMTV
exogenous viral sequences are absent in UDHs but are
present in 27% of ADHs, 82% of DCISs, and 35% of IDCs.
Normal epithelium collateral to DCIS is positive in 19% of
cases, whereas in noncollateral NEC, it is always nega-
tive (eg, when obtained by reductive mammoplasty) in
healthy women.
These data seem well in line with the model of progres-
sion usually accepted for breast cancer: normal epithe-
lium, UDH, ADH, DCIS, and IDC.43–48 ADH and DCIS are
considered obligatory precursors of IDC; ADH and low-
grade DCIS are included in the same category of DIN1,
ductal intraepithelial neoplasia. Usual-type epithelial hy-
perplasia represents a common finding in human breast,
as the result of a hormonal derearrangement. In fact, it is
considered to be not related to carcinogenesis, as shown
by its substantial polyclonality, the absence of chromo-
somal alterations, and the absence of dysregulation in
adhesion and extracellular matrix pathways. However,
there are a few cases (3%) that are monoclonal, with the
occurrence of loss of heterozygosity in up to 15% of
cases, with few chromosomal aberrations. Normal epithe-
lium can show molecular alterations similar to those oc-
curring in cancer, mainly in areas close to an invasive
carcinoma, as expected by the hypothesis of field carci-
nogenesis occurring in breast and other organs. In sum-
mary, the few epithelial cells transformed by the unknown
carcinogenic agent in a normal-looking breast glandular
structure, under the proliferative stimulus of estrogens,
can give origin to small neoplastic clones in a few UDHs,
which is a frequent benign alteration. The subsequent
expansion of the neoplastic clones, with the accumula-
tion of genomic aberrations, gives origin to ADHs, in
which nuclear atypia is easily evident.
Exogenous MMTVels are present in normal epithelium
close to IDCs in a small percentage of cases and have
not been found in normal epithelium of normal breast
tissue obtained by reductive mammoplasty or in UDHs
not associated with IDCs. MMTVels frequency is already
high in ADHs, then dramatically increases in IDCs, and
finally in IDCs goes back to a value similar to that of
ADHs.
The presence of MMTVels in IDCs, and in normal
breast, ADH, and DCIS, demonstrates that these exoge-
nous sequences represent an event bound to early steps
of carcinogenesis. The 35% positivity in IDCs is consistent
with previous data. The absence of positivity in normal
breast not associated with cancer, the few positive cases in
normal glandular structures close to IDCs, and the absence
of positivity in UDHs are in line with the field carcinogenesis
model and the biological characteristics of UDHs. The only
apparently controversial result is the high frequency of
MMTV env-like sequences in DCIS (80%), with a signifi-
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stream and downstream, ADH and IDC.
However, the high level of technological accuracy and
the robust controls used in this study strongly support the
reliability of the results. A possible explanation for the
strong decrease in positive cases moving from DCIS to
IDC can be that MMTVels are relevant for transformation,
but less important for transition, of DCISs to IDCs.
Moreover, MMTVels could be lost as a consequence of
the high level of chromosomal rearrangement charac-
terizing IDCs. A selective depletion of tumor cells ex-
pressing MMTV antigens can also be assumed, as a
consequence of their identification and elimination by
the immune system. These data are supported by re-
sults obtained by qPCR, demonstrating that the MMTV
env-like sequence copy number is small and that there
is a dramatic reduction moving from DCIS to IDC. In
addition, the copy number increases from normal cells
to DCIS.
The progressive increase in the number of positive
cases moving from normal cells to DCISs was previously
demonstrated by Ford et al16 during the dedifferentiation
of IDCs, moving from low- to high-grade cases. On the
other side, the benign lesions they studied (ie, fibroade-
noma and fibrocystic disease) are not comparable with
the preinvasive lesions analyzed herein.
Furthermore, and most important in this study, we re-
port for the first time to our knowledge, the presence of
the MMTV viral sequence by performing CISH experi-
ments in which we use a homemade probe of 2.7 kb
amplified from genomic DNA of a mouse infected with the
MMTV virus. We clearly demonstrate, as shown in Figure
4, the presence of the viral hybridization signal in the
nuclei of DCIS and IDC cells. The multiple signals coming
from each nucleus vary among cells and reflect the av-
erage number of signals (3.5) found by Liu et al27 in 2001,
when they conducted fluorescence in situ hybridization
experiments on breast cancer cell lines in metaphase. In
addition, the number of cells that present viral hybridiza-
tion signals is much fewer in the IDC cases than in the
DCISs, supporting the concept of a loss of viral sequence
load with the progression of the disease and, therefore,
enforcing the hypothesis that the viral sequences are
likely involved only in the initial transformation process.
Finally, a secondary, but not negligible, result of this
study is the demonstration that MMTV env gene-like se-
quences can be easily detected in formalin-fixed, paraf-
fin-embedded tissues.
In conclusion, exogenous MMTV sequences are easily
identifiable in the early steps of breast cancer progres-
sion, suggesting their possible role in the transformation
process, at least as an etiological cofactor. On the other
hand, the strong reduction of positive cases moving from
DCIS to IDC suggests that they are not relevant for the
progression of the disease. Our data encourage us to
pursue further research to definitively determine whether
there is a viral etiology of HBC. The isolation of the MMTV
virus from patients and the detection of its integration site
would represent relevant contributions.References
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